Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Minerva Neurosciences

Clinical trials sponsored by Minerva Neurosciences, explained in plain language.

Minerva Neurosciences NERV NASDAQ

A clinical-stage biopharmaceutical company developing treatments for central nervous system disorders.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New drug aims to ease tough schizophrenia symptoms

Symptom relief Recruiting now

This study tests a new drug called roluperidone for treating negative symptoms of schizophrenia, like lack of motivation and social withdrawal. About 380 adults with schizophrenia will take the drug or a placebo for 12 weeks to see if symptoms improve. Then, for 40 more weeks, re…

Phase: PHASE3 • Sponsor: Minerva Neurosciences • Aim: Symptom relief

Last updated Jul 30, 2026 00:00 UTC